Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kevin L. Luppen"'
Autor:
Richard N. Greenberg, Margaret Bollinger, William J. Weinandt, Lisa L. Ellington, Kevin L. Luppen, Patrick M. Reilly
Publikováno v:
Journal of Infectious Diseases. 153:277-282
We evaluated the following five treatment regimens for acute cystitis in nonpregnant women: cefadroxil, 1,000 mg single-dose; cefadroxil, 500 mg twice a day for three days; cefadroxil, 500 mg twice a day for seven days; trimethoprim-sulfamethoxazole
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::683c9e49aac969870cc873bc91e3d78e
https://doi.org/10.1093/infdis/153.2.277
https://doi.org/10.1093/infdis/153.2.277
Publikováno v:
The Prostate. 6:445-448
Twenty-three males with the clinical diagnosis of chronic prostatitis were evaluated for a bacterial etiology by the Stamey and Meares method. In addition, 16 patients, regardless of culture results, were placed on either cefadroxil or oral carbenici
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::165971da07858f2446b01126fb98e866
https://doi.org/10.1002/pros.2990060413
https://doi.org/10.1002/pros.2990060413
Autor:
Stephen M. Wolk, Richard N. Greenberg, Margaret Bollinger, Ray Mcmillian, Patrick M. Reilly, Kevin L. Luppen, Thakorbhai B. Darji, Amir A. Noorani
Publikováno v:
Journal of Infectious Diseases. 150:623-630
Aztreonam (SQ 26,776) is the first parenteral monobactam agent to be used in patient trials. The agent has significant activity in vitro against facultative aerobic gram-negative bacteria but not against gram-positive or anaerobic bacteria. Aztreonam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a12bdf8540639c73b47e4f84df9bf12e
https://doi.org/10.1093/infdis/150.5.623
https://doi.org/10.1093/infdis/150.5.623
Publikováno v:
The American journal of medicine. 78(2A)
Nineteen patients with community- or hospital-acquired gram-negative pneumonia were treated with aztreonam. Other gram-negative antibiotics were withheld. Thirteen patients (68 percent) had clinical cures and 15 (79 percent) had microbiologic cures w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::370675a398fdb1edffa6d8d68d3290a3
https://pubmed.ncbi.nlm.nih.gov/3918444
https://pubmed.ncbi.nlm.nih.gov/3918444